Marc Wolinsky has been a member of the Litigation Department at Wachtell, Lipton, Rosen & Katz since 1987. His practice includes corporate governance, contracts, antitrust, insurance and securities litigation.
Marc has been involved in a number of the most significant litigation battles in the Delaware Court of Chancery, leading the successful defense of Airgas’ “poison pill,” the successful effort to force Dow Chemical to close on its acquisition of Rohm and Haas, defending multi-forum shareholder litigation challenging JPMorgan’s acquisition of Bear Stearns, and litigating several high profile “material adverse change” cases. Marc also has successfully litigated numerous high stakes disputes in domestic and international arbitrations, state and federal courts and bankruptcy courts, as well as numerous derivative suits and securities class actions.
